What are people expectations for the first PR we get when discussions are done? Are investors expecting a just a top line report first? A EUA formal submission? PR stating sales contract for 100,000-500,000 doses per country? Or is there chance that FDA trying to control narrative and they would announce EUA or at least a meeting like they do with vaccines? This is out of the norm for FDA to have data first so just trying to figure out what order would we receive info given positive results confirmed enough for EUA.

I have seen some bashers like Breeze on other board already try to down play the possible scenario of if CYDY misses the Pvalue on 28 day primary endpoint but hits secondary endpoints for EUA. In my opinion and in reality our secondary endpoints of 42 or 60 days would likely be just as important as primary so no real difference on immediate billions in Revenue and saving lots of lives. I also think that full approval would be likely even at the 42 or 60. The numbers that we know of still trending toward achieving pvalue at day 28 and I believe we will hit it but I wanted to get out front the only things we need to see happen to put CYDY on the world map is to receive a EUA. It will likely lead to 4 initial countries receiving all of the available 1.2 million vials to USA MHRA Health Canada and Philippines. Very interested in how much of an manufacturing increase could be done especially with the help of those 3 countries health regulators and the likely hold CYDY successful in upcoming Long haulers trial which is slated to start early March. March 1st is Monday will there be a PR for highly anticipated long haulers trail before we get cd-12 trail results? And would it be better for SP to get that PR before or after cd-12.